ACE- Versus Chymase-Dependent Angiotensin II Generation in Human Coronary Arteries
Open Access
- 1 February 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (2) , 251-256
- https://doi.org/10.1161/01.atv.0000051875.41849.25
Abstract
Objective— The objective of this study was to investigate ACE- and chymase-dependent angiotensin I-to-II conversion in human coronary arteries (HCAs). Methods and Results— HCA rings were mounted in organ baths, and concentration-response curves to angiotensin II, angiotensin I, and the chymase-specific substrate Pro 11 - d -Ala 12 –angiotensin I (PA–angiotensin I) were constructed. All angiotensins displayed similar efficacy. For a given vasoconstriction, bath (but not interstitial) angiotensin II during angiotensin I and PA–angiotensin I was lower than during angiotensin II, indicating that interstitial (and not bath) angiotensin II determines vasoconstriction. PA–angiotensin I increased interstitial angiotensin II less efficiently than angiotensin I. Separate inhibition of ACE (with captopril) and chymase (with C41 or chymostatin) shifted the angiotensin I concentration-response curve ≈5-fold to the right, whereas a 10-fold shift occurred during combined ACE and chymase inhibition. Chymostatin, but not captopril and/or C41, reduced bath angiotensin II and abolished PA–Ang I–induced vasoconstriction. Perfused HCA segments, exposed luminally or adventitially to angiotensin I, released angiotensin II into the luminal and adventitial fluid, respectively, and this release was blocked by chymostatin. Conclusions— Both ACE and chymase contribute to the generation of functionally active angiotensin II in HCAs. However, because angiotensin II loss in the organ bath is chymase-dependent, ACE-mediated conversion occurs more efficiently (ie, closer to AT 1 receptors) than chymase-mediated conversion.Keywords
This publication has 13 references indexed in Scilit:
- Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failureJournal of the American College of Cardiology, 2002
- Vasoconstriction is determined by interstitial rather than circulating angiotensin IIBritish Journal of Pharmacology, 2002
- Intrarenal angiotensin II: Interstitial and cellular levels and site of productionKidney International, 2001
- Angiotensin converting enzyme is the main contributor to angiotensin I–II conversion in the interstitium of the isolated perfused rat heartJournal Of Hypertension, 2001
- Mast cell chymase expression and mast cell phenotypes in human rejected kidneysKidney International, 2001
- A novel vascular smooth muscle chymase is upregulated in hypertensive ratsJournal of Clinical Investigation, 2001
- Cardiac intersitial fluid levels of angiotensin I and II in the pigJournal Of Hypertension, 1999
- Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin IICardiovascular Research, 1999
- Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.Journal of Clinical Investigation, 1993
- Reactive Hyperreninemia Is a Major Determinant of Plasma Angiotensin II During ACE InhibitionJournal of Cardiovascular Pharmacology, 1990